ArticleCureus2026
Comparative Analysis of Hyperbilirubinemia Between Congenital Hypothyroidism and Euthyroidism in Neonates in Rawalpindi, Pakistan.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionNeonatal hyperbilirubinemia is a prevalent clinical observation that, if persistent or severe, may suggest underlying endocrine abnormalities such as congenital hypothyroidism (CH). Thyroid hormones play a crucial role in liver function and the metabolism of bilirubin.
objectiveThis study aimed to evaluate blood bilirubin and thyroid stimulating hormone (TSH) levels in neonates diagnosed with CH compared to those with normal thyroid function (euthyroid). MATERIAL AND
methodsA comparative cross-sectional observational study was conducted at Majeed Medical & Gynae Complex and Farid Medical Family Hospital in Rawalpindi, Pakistan. A total of 200 neonates, aged 1-30 days, were included in the study, comprising 100 confirmed cases of CH and 100 controls. The clinical features and demographics of patients were recorded using a structured interview questionnaire. Serum bilirubin and TSH levels were measured using automated Roche analyzers (C-311 and E-411). Data were analyzed utilizing IBM SPSS Statistics for Windows, version 25 (IBM Corp., Armonk, New York, United States) and GraphPad Prism (Dotmatics, Boston, Massachusetts, United States).
resultsProlonged jaundice was the most prevalent (74%) clinical finding among the CH group. Mean bilirubin (total, direct, and indirect) levels and TSH levels were analyzed using an independent t-test, with a significance threshold set at p < 0.01. A positive significant correlation exists between TSH levels and bilirubin (total and indirect) concentration in the hypothyroid group, with a p-value of < 0.01. These findings highlight the clinical significance of timely newborn TSH screening and the early administration of levothyroxine to mitigate jaundice-related morbidity and prevent unnecessary phototherapy or extended hospitalization.
conclusionThe current study concludes that newborns with CH have markedly increased all types of bilirubin levels relative to euthyroid newborns, and there is a statistically significant positive correlation between TSH levels and bilirubin levels (total and indirect).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.